A new class action filed against ADMA Biologics (ADMA) alleges securities fraud and urges investors to seek recovery, with a lead-plaintiff deadline of 8/10/2026. The filing is a near-term legal overhang but no financial results or damages were specified in the news item.
A new class action filed against ADMA Biologics (ADMA) alleges securities fraud and urges investors to seek recovery, with a lead-plaintiff deadline of 8/10/2026. The filing is a near-term legal overhang but no financial results or damages were specified in the news item.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
